Polythiazide/Reserpine

多噻嗪/利血平

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePolythiazide/Reserpine
Drug Alias NameReserpine/Polythiazide利血平/多噻嗪polythiazide and reserpineReserpine and PolythiazideRenese-r
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsSynaptic vesicular amine transporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterSynaptic vesicular amine transporter
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1963/10/15
Country/TerritoryUnited States
CombinationsYes PolythiazideReserpine
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC02LA01
Related LinksN/A